Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/ILMN

ILMN

Illumina, Inc.

Healthcare - US

Illumina, Inc. is a global life sciences company specializing in developing, manufacturing, and marketing integrated systems and tools for genetic and genomic analysis. Its core products and services include next-generation sequencing (NGS)…

HQ: San Diego, CA, United States of Americawww.illumina.com

USD206.45+2.57%vs prev. close

Market snapshot

Price

USD206.45

Daily move

+2.57%

P/E

38.4

EPS TTM

5.37

Dividend yield

—

Beta

1.47

Market cap

31.2B

Price history

ILMN price

USD

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
Illumina	ILMN	Diagnostics & Research	31.2	38.4	—	-5.4%	+7.0%	+28.3%	+73.6%	+107.9%	+57.4%

Subscribe to Equity Analytics to compare ILMN with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.